Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study

Fig. 3

Local control of bone metastases. a Local control of all bone metastatic bone lesions. b Primary tumor sites (favorable group vs. moderately unfavorable group vs. unfavorable group; favorable group: head and neck, lung/mediastinal, breast, gastric, gynecologic, prostate, bladder, and skin cancers; moderately unfavorable group: kidney/ureter and non-epithelial cancers; unfavorable group: esophageal, colorectal, and hepatobiliary/pancreatic cancers). c EBRT sites (vertebral bone vs. other bone). d EBRT dose (BED10) (< 39.0 Gy vs. 39.0 Gy vs. > 39.0 Gy). BED Biologically effective dose, EBRT external beam radiotherapy

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us